Search Results - "Dowling, Quinton M."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Computational design of constitutively active cGAS by Dowling, Quinton M., Volkman, Hannah E., Gray, Elizabeth E., Ovchinnikov, Sergey, Cambier, Stephanie, Bera, Asim K., Sankaran, Banumathi, Johnson, Max R., Bick, Matthew J., Kang, Alex, Stetson, Daniel B., King, Neil P.

    Published in Nature structural & molecular biology (01-01-2023)
    “…Cyclic GMP–AMP synthase (cGAS) is a pattern recognition receptor critical for the innate immune response to intracellular pathogens, DNA damage, tumorigenesis…”
    Get full text
    Journal Article
  2. 2

    Particle Sizing of Nanoparticle Adjuvant Formulations by Dynamic Light Scattering (DLS) and Nanoparticle Tracking Analysis (NTA) by Chan, Michelle Y, Dowling, Quinton M, Sivananthan, Sandra J, Kramer, Ryan M

    “…Dynamic light scattering (DLS) and nanoparticle tracking analysis (NTA) are two orthogonal and complementary methods of measuring size of particles in a…”
    Get more information
    Journal Article
  3. 3

    Quantification of Multiple Components of Complex Aluminum-Based Adjuvant Mixtures by Using Fourier Transform Infrared Spectroscopy and Partial Least Squares Modeling by Dowling, Quinton M, Kramer, Ryan M

    “…Fourier transform infrared (FTIR) spectroscopy is widely used in the pharmaceutical industry for process monitoring, compositional quantification, and…”
    Get more information
    Journal Article
  4. 4

    In vitro evaluation of TLR4 agonist activity: Formulation effects by Misquith, Ayesha, Fung, H.W. Millie, Dowling, Quinton M., Guderian, Jeffrey A., Vedvick, Thomas S., Fox, Christopher B.

    Published in Colloids and surfaces, B, Biointerfaces (01-01-2014)
    “…•TLR4 ligands are promising vaccine adjuvant candidates.•In vitro assays (e.g. macrophage cytokine production) evaluate adjuvant activity.•Different…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization by Orr, Mark T., Kramer, Ryan M., Barnes, Lucien, Dowling, Quinton M., Desbien, Anthony L., Beebe, Elyse A., Laurance, John D., Fox, Christopher B., Reed, Steven G., Coler, Rhea N., Vedvick, Thomas S.

    Published in Journal of controlled release (10-03-2014)
    “…Next-generation rationally-designed vaccine adjuvants represent a significant breakthrough to enable development of vaccines against challenging diseases…”
    Get full text
    Journal Article
  7. 7

    Working together: interactions between vaccine antigens and adjuvants by Fox, Christopher B., Kramer, Ryan M., Barnes V, Lucien, Dowling, Quinton M., Vedvick, Thomas S.

    Published in Therapeutic advances in vaccines (01-05-2013)
    “…The development of vaccines containing adjuvants has the potential to enhance antibody and cellular immune responses, broaden protective immunity against…”
    Get full text
    Journal Article
  8. 8

    Quantitative measurement of Toll-like receptor 4 agonists adsorbed to Alhydrogel(®) by Fourier transform infrared-attenuated total reflectance spectroscopy by Dowling, Quinton M, Schwartz, Alicia M, Vedvick, Thomas S, Fox, Christopher B, Kramer, Ryan M

    Published in Journal of pharmaceutical sciences (01-02-2015)
    “…Aluminum salts have a long history as safe and effective vaccine adjuvants. In addition, aluminum salts have high adsorptive capacities for vaccine antigens…”
    Get more information
    Journal Article
  9. 9

    Cryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomes by Fox, Christopher B, Mulligan, Sean K, Sung, Joyce, Dowling, Quinton M, Fung, H W Millie, Vedvick, Thomas S, Coler, Rhea N

    Published in International journal of nanomedicine (01-01-2014)
    “…Development of lipid-based adjuvant formulations to enhance the immunogenicity of recombinant vaccine antigens is a focus of modern vaccine research…”
    Get full text
    Journal Article
  10. 10

    Lyophilization of an Adjuvanted Mycobacterium tuberculosis Vaccine in a Single-Chamber Pharmaceutical Cartridge by Barnes V, Lucien, Fedor, Dawn M., Williams, Simon, Dowling, Quinton M., Archer, Michelle C., Cloutier, Sylvain, Parker, Sarah, Vedvick, Thomas S., Fox, Christopher B., Kramer, Ryan M.

    Published in AAPS PharmSciTech (01-08-2017)
    “…Although substantial effort has been made in the development of next-generation recombinant vaccine systems, maintenance of a cold chain is still typically…”
    Get full text
    Journal Article
  11. 11

    Modulating potency: Physicochemical characteristics are a determining factor of TLR4-agonist nanosuspension activity by Dowling, Quinton M, Sivananthan, Sandra J, Guderian, Jeff A, Moutaftsi, Magdalini, Chesko, James D, Fox, Christopher B, Vedvick, Thomas S, Kramer, Ryan M

    Published in Journal of pharmaceutical sciences (01-03-2014)
    “…Activity of adjuvanted vaccines is difficult to predict in vitro and in vivo. The wide compositional and conformational range of formulated adjuvants, from…”
    Get more information
    Journal Article
  12. 12

    Methods and Applications of Computational Design in Multiple States by Dowling, Quinton M

    Published 01-01-2023
    “…The balance between flexibility and stability is a key property of proteins, contributing to the vast area of structures and functions observed in nature…”
    Get full text
    Dissertation